What are the key takeaways from this a16z Podcast episode?

Key insights include: **Clinical AI adoption threshold:** Vendors claiming AI capabilities routinely achieve only 20-30% clinician adoption at health systems, making 75%+ daily utilization the true benchmark for enterprise viability. Health system CEOs should demand utilization data before purchasing, since low adoption renders any downstream ROI claims meaningless regardless of how compelling the vendor pitch sounds.; **AI product clock speed vs. AI model clock speed:** Building healthcare AI requires separating foundation model iteration cycles from product deployment cycles. Ambiance maintains a dedicated infrastructure layer that pulls and normalizes data from any EHR instance, reducing the incremental cost of launching each new use case and enabling the company to scale from 2 to 24 products without rebuilding integrations from scratch each time.; **Decision traces as the critical data asset:** Most EHRs use mutable data structures that destroy clinical decision traces — the sequential record of how a clinician reasoned toward a diagnosis or code. Companies building durable healthcare AI must architect systems that capture immutable decision traces from the start, since this data is what enables domain-specific post-training that generalist foundation models cannot replicate.

What did Nikhil Budhama and Julie Yu discuss on a16z Podcast?

Nikhil Buduma, CEO of Ambiance Healthcare, discusses deploying AI in clinical settings with a16z's Julie Yu. Ambiance reaches 75% daily clinician adoption at major academic medical centers, with one health system projecting $30M in net new margin from the platform across documentation, coding, and revenue cycle use cases. Key topics include: **Clinical AI adoption threshold:** Vendors claiming AI capabilities routinely achieve only 20-30% clinician adoption at health systems, making 75%+ daily utilization the true benchmark for enterprise viability. Health system CEOs should demand utilization data before purchasing, since low adoption renders any downstream ROI claims meaningless regardless of how compelling the vendor pitch sounds.; **AI product clock speed vs. AI model clock speed:** Building healthcare AI requires separating foundation model iteration cycles from product deployment cycles. Ambiance maintains a dedicated infrastructure layer that pulls and normalizes data from any EHR instance, reducing the incremental cost of launching each new use case and enabling the company to scale from 2 to 24 products without rebuilding integrations from scratch each time..

How long is this episode of a16z Podcast?

This episode is 49 minutes long. SignalCast provides an AI-generated summary so you can get the key insights in about 3 minutes.

a16z Podcast

Deploying AI in Healthcare

March 4, 2026

49 min episode · 2 min read

Nikhil Budhama,Julie Yu

Episode

49 min

Read time

2 min

Topics

Productivity, Health & Wellness, Fundraising & VC

AI-Generated Summary

Published Mar 5, 2026

Key Takeaways

✓Clinical AI adoption threshold: Vendors claiming AI capabilities routinely achieve only 20-30% clinician adoption at health systems, making 75%+ daily utilization the true benchmark for enterprise viability. Health system CEOs should demand utilization data before purchasing, since low adoption renders any downstream ROI claims meaningless regardless of how compelling the vendor pitch sounds.
✓AI product clock speed vs. AI model clock speed: Building healthcare AI requires separating foundation model iteration cycles from product deployment cycles. Ambiance maintains a dedicated infrastructure layer that pulls and normalizes data from any EHR instance, reducing the incremental cost of launching each new use case and enabling the company to scale from 2 to 24 products without rebuilding integrations from scratch each time.
✓Decision traces as the critical data asset: Most EHRs use mutable data structures that destroy clinical decision traces — the sequential record of how a clinician reasoned toward a diagnosis or code. Companies building durable healthcare AI must architect systems that capture immutable decision traces from the start, since this data is what enables domain-specific post-training that generalist foundation models cannot replicate.
✓Revenue cycle as the primary financial ROI driver: Early AI scribe adoption was justified primarily by clinician retention and satisfaction, not hard financials. The shift to measurable ROI now comes from linking ambient documentation directly to coding accuracy, CDI query prevention, denial reduction, and net cash collected — requiring vendors to download EHR data warehouses and build CFO-grade attribution analytics to prove the margin impact.
✓Pre-visit and post-visit agents as the next expansion layer: The near-term product frontier beyond ambient documentation involves deploying agents that gather patient context before appointments and conduct structured follow-up after visits — confirming medication pickup, lab completion, and pre-procedure preparation. This virtual care team model expands clinician panel capacity without increasing physician workload or requiring additional headcount.

What It Covers

Nikhil Buduma, CEO of Ambiance Healthcare, discusses deploying AI in clinical settings with a16z's Julie Yu. Ambiance reaches 75% daily clinician adoption at major academic medical centers, with one health system projecting $30M in net new margin from the platform across documentation, coding, and revenue cycle use cases.

Key Questions Answered

•Clinical AI adoption threshold: Vendors claiming AI capabilities routinely achieve only 20-30% clinician adoption at health systems, making 75%+ daily utilization the true benchmark for enterprise viability. Health system CEOs should demand utilization data before purchasing, since low adoption renders any downstream ROI claims meaningless regardless of how compelling the vendor pitch sounds.
•AI product clock speed vs. AI model clock speed: Building healthcare AI requires separating foundation model iteration cycles from product deployment cycles. Ambiance maintains a dedicated infrastructure layer that pulls and normalizes data from any EHR instance, reducing the incremental cost of launching each new use case and enabling the company to scale from 2 to 24 products without rebuilding integrations from scratch each time.
•Decision traces as the critical data asset: Most EHRs use mutable data structures that destroy clinical decision traces — the sequential record of how a clinician reasoned toward a diagnosis or code. Companies building durable healthcare AI must architect systems that capture immutable decision traces from the start, since this data is what enables domain-specific post-training that generalist foundation models cannot replicate.
•Revenue cycle as the primary financial ROI driver: Early AI scribe adoption was justified primarily by clinician retention and satisfaction, not hard financials. The shift to measurable ROI now comes from linking ambient documentation directly to coding accuracy, CDI query prevention, denial reduction, and net cash collected — requiring vendors to download EHR data warehouses and build CFO-grade attribution analytics to prove the margin impact.
•Pre-visit and post-visit agents as the next expansion layer: The near-term product frontier beyond ambient documentation involves deploying agents that gather patient context before appointments and conduct structured follow-up after visits — confirming medication pickup, lab completion, and pre-procedure preparation. This virtual care team model expands clinician panel capacity without increasing physician workload or requiring additional headcount.

Notable Moment

Buduma describes receiving a direct email from a physician at an Ambiance customer site who tracked down an investor contact specifically to express that the product reversed their decision to leave medicine — a reversal from the prior era when doctors openly resisted each new software tool added to their workflow.

Know someone who'd find this useful?

Episode Transcript

We live in a world where the demand for health care is just rising so quickly. We have 10,000 people aging into Medicare every single day, and we just can't train doctors fast enough to take care of all these people. The practice surface area for the clinician will look fundamentally different in the next three to five years. When I was deploying my own software back in the day, doctors would grow and then they'd be like, oh, you had another tool? Like, why are you stuffing this down my throat? The delta between the magic of the tool that they're experiencing in their consumer lives and what they do in their work has for the first time narrowed just even a little bit to a point where it's just fundamentally changed the nature of how they view technology. I think this is the first time where there's hope. There is a pathway to doing more with less. There is a pathway for the job of being a clinician, being a nurse, to be fulfilling one. There is a pathway for the experience of a patient not being as confusing and full of despair as sometimes it is. When Nikhil Budhama was a PhD student at Stanford, he lost a mentor to a medical error. Instead of finishing his MD PhD, he dropped out to work on fixing health care with technology. He spent years in the early deep learning community, including time with the researchers who would go on to found OpenAI. He watched transformers emerge in 2017 and saw the scaling laws start to click. Then he did something unusual. He and his cofounder started a medical practice, not to deliver care forever, but to understand what it actually feels like to run one, to work with doctors, implement an EHR, and see where technology falls short. That experience became the foundation for Ambiance. Today, the company works with some of the largest academic medical centers in the country, over 75% of clinicians use the product daily, and one health system is projecting $30,000,000 in net new margin from the platform. A 16 z general partner, Julie Yu, talks with Nikhil Budhama, CEO and cofounder of Ambiance Health Care. Super excited to have you here, Nikhil Budhama, who is the CEO of Ambiance, one of the cofounders. And Ambiance, I feel like, you know, you guys were founded, what, twenty Twenty twenty. 2020. I think we were the first investment you made on Zoom. Yes. On Zoom. That's right. Right when COVID was hitting and everyone was going crazy. But even crazier is what has happened in the last, what, you know, five plus years on the AI front. And you sort of had a front row seat to the whole thing. So you should share a little bit about your background, how you got involved in this whole crazy AI space, and then what's it been like to, you know, be at the helm of one …

Get the full transcript (9,899 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all a16z Podcast transcripts →